A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
AO GENERIUM
AO GENERIUM
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
Celularity Incorporated
Beijing Immunochina Medical Science & Technology Co., Ltd.
Blueprint Medicines Corporation